Year: 2025

Petah Tikvah, Israel, Jan. 13, 2025 (GLOBE NEWSWIRE) — SaverOne 2014 Ltd. (Nasdaq: SVRE, TASE: SVRE), a technology leader in advanced transportation safety solutions, is pleased to announce a new distribution agreement with uniSmart Vertriebs GmbH (“uniSmart”), a prominent German-based distributor specializing in fleet safety and technology integration. uniSmart, headquartered in Wendendelstein, provides solutions for logistics and transportation companies across Germany and abroad. The company resells, installs, and provides support for advanced fleet management and safety systems, including Webfleet technology, for a variety of fleet sizes and industries. uniSmart’s client base includes major national German transport operators and many medium-sized fleets. Mr. Ori Gilboa, CEO of SaverOne, commented, “We continue our strong...

THE WOODLANDS, TX, Jan. 13, 2025 (GLOBE NEWSWIRE) — Autonomix Medical, Inc. (NASDAQ: AMIX) (“Autonomix” or the “Company”), a medical device company focused on advancing innovative technologies to revolutionize how diseases involving the nervous system are diagnosed and treated, today announced its abstract has been accepted for poster presentation at the SIO 2025 Annual Scientific Meeting, being held January 30 – February 3, 2025 in Las Vegas, NV. Details of the accepted abstract are as follows: Title: Ablation of the Celiac Ganglia for Treatment of Pancreatic Cancer Pain: An Interim Analysis of the First Five “Lead-In” PatientsAuthor: Rob Schwartz, M.D., Chief Medical Officer of Autonomix SIO is a non-profit organization dedicated to promoting and supporting the field of interventional oncology (IO), aiming to establish it as...

– Topline data from the first Phase 3 FOS study anticipated in H2 2025 representing major milestone in support of NDA filing and potential launch of azetukalner – First of three planned Phase 3 MDD studies now initiated – Expanding ion channel portfolio includes Kv7 and Nav1.7 candidates advancing towards IND filings in 2025 VANCOUVER, British Columbia and BOSTON, Jan. 13, 2025 (GLOBE NEWSWIRE) — Xenon Pharmaceuticals Inc. (Nasdaq: XENE), a neuroscience-focused biopharmaceutical company dedicated to discovering, developing, and delivering life-changing therapeutics for patients in need, today outlined progress within its pipeline programs and key milestones for 2025. “Reflecting on our accomplishments in 2024, we are proud of the advancements in our late-stage clinical programs, culminating in a strong presence at AES where we...

TOKYO, Jan. 13, 2025 (GLOBE NEWSWIRE) — Lead Real Estate Co., Ltd. (Nasdaq: LRE) (“LRE” or “the Company”), a Japanese real estate developer of luxury residential properties including single-family homes and condominiums across Tokyo, Kanagawa prefecture and Sapporo, today announced that in December 2024, it completed the sale and delivery of two newly built luxury income-producing condominium buildings in prime locations in Tokyo. A 3-unit property, Excelsior Nishi Azabu 2 Chome, in Minato-ku, Nishi Azabu, is made from reinforced concrete, has one basement floor and three floors above ground. It has a building area of 4,985 square feet and a land area of 2,238 square feet. A high-end residential neighborhood surrounded by traditional stores, Nishi Azabu has convenient access to financial centers and elegant shopping districts. The...

SAN CLEMENTE, Calif., Jan. 13, 2025 (GLOBE NEWSWIRE) — Sofwave Medical Ltd (TASE: SOFW), an emerging leader in energy-based non-invasive, aesthetic medical devices for practitioners worldwide, reports preliminary financial results for the fourth quarter and full fiscal year, for the period ended December 31, 2024. Preliminary financial resultsFourth quarter 2024 revenue is expected to total between $18.2 million and $18.4 million, as compared to approximately $15.3 million in the same period last year, reflecting an increase of approximately 20% compared to the same period last year. Full fiscal 2024 revenue is expected to total between $59.5 million and $59.7 million, as compared to approximately $50.3 million in the same period last year, reflecting an increase of approximately 19% compared to the same period last year. Cash...

HOUSTON, Jan. 13, 2025 (GLOBE NEWSWIRE) — Systemic Bio™, a 3D Systems company (NYSE: DDD), is honored to announce its selection as a Top 10 Finalist for the prestigious SLAS 2025 Innovation Award. This recognition underscores the groundbreaking potential of Systemic Bio’s proprietary h-VIOS™ platform geared at accelerating drug discovery and development using human-relevant data from bioprinted tissues. The SLAS Innovation Award, presented annually at the SLAS International Conference and Exhibition, celebrates the most innovative technologies poised to impact laboratory science and automation. Systemic Bio was recognized for its cutting-edge platform, which leverages advanced bioprinting technologies to create complex vascularized tissue models. “We are thrilled to be recognized by SLAS as a Top 10 Finalist for their...

SAN FRANCISCO, Jan. 13, 2025 (GLOBE NEWSWIRE) — iRhythm Technologies, Inc. (NASDAQ:IRTC) a leading digital health care company focused on creating trusted solutions that detect, predict, and prevent disease, today announced preliminary fourth quarter operational highlights and a business update at the 43rd Annual J.P. Morgan Healthcare Conference. Recent Operational Highlights and Financial OutlookAnticipate full year 2024 revenue slightly above high end of previously stated guidance range of $587.5 million provided in October 2024 Record quarter of new account openings for both Zio monitor and Zio AT during the fourth quarter 2024 as well as strong volume contributions from large national accounts Launched first four health care systems on Epic Aura during the fourth quarter 2024 with broad commercial roll out for Epic health...

Hellmuth to Bring His Bigger Than Life Personality Exclusively to Rush Street Interactive CHICAGO, Jan. 13, 2025 (GLOBE NEWSWIRE) — Rush Street Interactive, Inc. (NYSE: RSI) (“RSI”), a premier online casino and sports betting operator, is thrilled to announce a new exclusive partnership with Phil Hellmuth, the world-renowned professional poker player and record-holder for the most World Series of Poker (WSOP) tournament wins. Known as one of the most skilled gamblers in the world, Hellmuth will join the BetRivers team as a brand and content partner bringing his unparalleled expertise and charisma to deliver a variety of exciting and exclusive player experiences and entertainment across RSI’s Casino, Sportsbook, and Poker verticals, as well as throughout RSI’s media-owned productions such as the BetRivers Network and our long-running...

ATR-Targeted Molecules Designed for CNS Penetration Set the Stage for Next-Generation Treatments VANCOUVER, British Columbia, Jan. 13, 2025 (GLOBE NEWSWIRE) — Rakovina Therapeutics Inc. (TSX-V: RKV), a biopharmaceutical company dedicated to advancing new cancer therapies based on novel DNA-damage response technologies, is pleased to announce the successful achievement of a shortlist of AI-generated molecules targeting ATR (Ataxia Telangiectasia and Rad3-related protein) with specific designs for central nervous system (CNS) penetration. This milestone represents the first significant deliverable in Rakovina’s partnership with Variational AI, which leverages their state-of-the-art Enki™ platform to fast-track the discovery of innovative inhibitors for specific DNA damage response (DDR) kinase targets. ATR is an important...

Mr. Wilson has a Track Record of Leading Product Launches and Achieving Revenue Growth in the Endovascular Devices Market BRAINTREE, Mass., Jan. 13, 2025 (GLOBE NEWSWIRE) — Microbot Medical Inc. (Nasdaq: MBOT), developer of the innovative LIBERTY® Endovascular Robotic System, is continuing its transition into a commercially focused company with the election of David J. Wilson to the Board of Directors. Mr. Wilson is a seasoned healthcare executive with a background of commercial success and revenue growth in the endovascular devices market. Mr. Wilson’s career spans over 30 years and includes broad, global leadership expertise in business strategy and operations, R&D, commercial readiness and product launches. He dedicated two decades in roles of increasing responsibility with various Johnson and Johnson (J&J) companies,...